Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554133 · ClinicalTrials.gov registry record · NA
Precision Optical Guidance for Oral Biopsy
A NA study of Oral Lesions, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05554133 is a NA study of Oral Lesions that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05554133, a NA study of Oral Lesions, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.
Conditions Studied
Interventions
- DEVICE High Resolution Microendoscope (HRME)
- DEVICE Optical Mapping Scope
- DRUG Proflavine hemisulfate
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05554133
The ClinicalTrials.gov registry entry for NCT05554133 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Oral Lesions appearing as the primary indexed condition, and to 3 interventions - of which High Resolution Microendoscope (HRME) is the first listed.
NCT05554133 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05554133 about?
NCT05554133 is a clinical study titled "Precision Optical Guidance for Oral Biopsy". To learn if a new type of imaging device called the Active Biopsy Guidance System can help doctors to decide when and where to perform invasive biopsies of mouth lesions.
What is the current status of trial NCT05554133?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-06-15. Estimated completion is 2027-03-31.
What conditions does trial NCT05554133 study?
This clinical trial studies the following conditions: Oral Lesions.
What interventions are being tested in trial NCT05554133?
The interventions under investigation include: High Resolution Microendoscope (HRME) (DEVICE), Optical Mapping Scope (DEVICE), Proflavine hemisulfate (DRUG).
Who is sponsoring clinical trial NCT05554133?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05554133 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.